Education and Training
- Medical Oncology Fellowship, University of Texas MD Anderson Cancer Center, 1999 - 2002
- Internal Medicine Residency, Beth Israel Deaconess Medical Center, 1996 - 1999
- M.D., Boston University School of Medicine, 1996
Pathak, A. K., J. C. Shiau, M. B. Thomas, and C. C. Murdock. “Field Relevant Variation in Ambient Temperature Modifies Density-Dependent Establishment of Plasmodium falciparum Gametocytes in Mosquitoes.” Frontiers in Microbiology 10 (November 15, 2019). https://doi.org/10.3389/fmicb.2019.02651.
Barreaux, Antoine M. G., Welbeck A. Oumbouke, Innocent Zran Tia, N’guessan Brou, Alphonsine A. Koffi, Raphaël N’guessan, and Matthew B. Thomas. “Semi-field evaluation of the cumulative effects of a "Lethal House Lure" on malaria mosquito mortality..” Malar J 18, no. 1 (August 30, 2019). https://doi.org/10.1186/s12936-019-2936-2.
Friday, Benjamin, Yvonne Lassere, Christina A. Meyers, Akira Mita, James L. Abbruzzese, and Melanie B. Thomas. “A phase I study to determine the safety and pharmacokinetics of intravenous administration of TAS-106 once per week for three consecutive weeks every 28 days in patients with solid tumors..” Anticancer Res 32, no. 5 (May 2012): 1689–96.
Hammond-Thelin, Lisa A., Melanie B. Thomas, Michiko Iwasaki, James L. Abbruzzese, Yvonne Lassere, Christina A. Meyers, Paulo Hoff, et al. “Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies..” Invest New Drugs 30, no. 1 (February 2012): 316–26. https://doi.org/10.1007/s10637-010-9535-y.
Kaseb, Ahmed O., E. Garrett-Mayer, J. S. Morris, L. Xiao, E. Lin, G. Onicescu, M. M. Hassan, et al. “Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial..” Oncology 82, no. 2 (2012): 67–74. https://doi.org/10.1159/000335963.
Hassan, Manal M., Ahmed Kaseb, Donghui Li, Yehuda Z. Patt, Jean-Nicolas Vauthey, Melanie B. Thomas, Steven A. Curley, et al. “Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States..” Hepatology 49, no. 5 (May 2009): 1563–70. https://doi.org/10.1002/hep.22793.
Thomas, Melanie B., Jeffrey S. Morris, Romil Chadha, Michiko Iwasaki, Harmeet Kaur, E. Lin, Ahmed Kaseb, Katrina Glover, Marta Davila, and James Abbruzzese. “Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma..” J Clin Oncol 27, no. 6 (February 20, 2009): 843–50. https://doi.org/10.1200/JCO.2008.18.3301.
Hassan, Manal M., Margret R. Spitz, Melanie B. Thomas, Steven A. Curley, Yehuda Z. Patt, Jean-Nicolas Vauthey, Katrina Y. Glover, et al. “The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States..” J Hepatol 50, no. 2 (February 2009): 334–41. https://doi.org/10.1016/j.jhep.2008.08.016.